Novonesis (Novozymes) A/S Cash Flow Quality Index
Novonesis (Novozymes) A/S cash flow quality index. Novonesis (Novozymes) A/S (NSIS-B) has a Cash Flow Quality Index of 0.84x as of March 2026. Operating cash flow of Dkr167.06 Million is below net income of Dkr199.05 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Novonesis (Novozymes) A/S cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Novonesis (Novozymes) A/S (2002–2025)
Cash flow quality index of Novonesis (Novozymes) A/S from 2002 to 2025. Historical Cash Flow Quality Index for Novonesis (Novozymes) A/S across 24 annual periods. Values consistently above 1.0x indicate high-quality earnings. See net asset quality index of Novonesis (Novozymes) A/S to measure how much of total assets are equity-financed.
Novonesis (Novozymes) A/S Cash Flow Quality Index by Year (2002–2025)
Novonesis (Novozymes) A/S cash flow quality index by year from 2002 to 2025. Year-by-year earnings quality comparison for Novonesis (Novozymes) A/S. For the full cash flow conversion analysis, see Novonesis (Novozymes) A/S cash conversion from operations.
| Year | Quality Index | Operating CF (DKK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.09x | Dkr1.22 Billion | Dkr583.60 Million | ▼ -37.2% |
| 2024 | 3.34x | Dkr1.02 Billion | Dkr305.80 Million | ▲ +142.9% |
| 2023 | 1.37x | Dkr4.15 Billion | Dkr3.02 Billion | ▲ +26.3% |
| 2022 | 1.09x | Dkr4.01 Billion | Dkr3.69 Billion | ▼ -15.9% |
| 2021 | 1.29x | Dkr4.06 Billion | Dkr3.15 Billion | ▼ -16.2% |
| 2020 | 1.54x | Dkr4.36 Billion | Dkr2.83 Billion | ▲ +52.1% |
| 2019 | 1.01x | Dkr3.20 Billion | Dkr3.15 Billion | ▼ -11.1% |
| 2018 | 1.14x | Dkr3.68 Billion | Dkr3.23 Billion | ▼ -12.5% |
| 2017 | 1.30x | Dkr4.06 Billion | Dkr3.12 Billion | ▲ +3.5% |
| 2016 | 1.26x | Dkr3.84 Billion | Dkr3.05 Billion | ▲ +6.4% |
| 2015 | 1.18x | Dkr3.34 Billion | Dkr2.82 Billion | ▼ -34.0% |
| 2014 | 1.79x | Dkr4.53 Billion | Dkr2.53 Billion | ▲ +51.6% |
| 2013 | 1.18x | Dkr2.60 Billion | Dkr2.20 Billion | ▼ -13.6% |
| 2012 | 1.37x | Dkr2.76 Billion | Dkr2.02 Billion | ▼ -7.7% |
| 2011 | 1.48x | Dkr2.71 Billion | Dkr1.83 Billion | ▲ +2.9% |
| 2010 | 1.44x | Dkr2.32 Billion | Dkr1.61 Billion | ▼ -5.4% |
| 2009 | 1.52x | Dkr1.82 Billion | Dkr1.19 Billion | ▼ -4.8% |
| 2008 | 1.60x | Dkr1.70 Billion | Dkr1.06 Billion | ▼ -2.9% |
| 2007 | 1.64x | Dkr1.71 Billion | Dkr1.04 Billion | ▼ -2.3% |
| 2006 | 1.68x | Dkr1.53 Billion | Dkr911.00 Million | ▲ +9.3% |
| 2005 | 1.54x | Dkr1.33 Billion | Dkr861.00 Million | ▼ -5.1% |
| 2004 | 1.62x | Dkr1.29 Billion | Dkr793.00 Million | ▼ -13.2% |
| 2003 | 1.87x | Dkr1.37 Billion | Dkr735.00 Million | ▲ +2.4% |
| 2002 | 1.83x | Dkr1.18 Billion | Dkr647.00 Million | — |